| | ENG

For Investigators Only

CN102a: Phase II Lithium Trial
This Phase 2 randomized double-blind placebo-controlled trial is to assess the efficacy of 6-week course of oral lithium in patients with chronic spinal cord injury. It was conducted by China Rehabilitation Research Center, Beijing, in 2008-2009 and by Buddhist Tzuchi Hospital, Taichung, in 2009-2010.

Study Sites: China Rehabilitation Research Center (Beijing) and Buddhist Tzuchi Hospital (Taichung)

Principal Investigators: Dr. Jianjun LI and Dr. Tzu-Yung CHEN

No. of Subjects enrolled: 57

Sponsorship: Hong Kong Spinal Cord Injury Fund (HKSCIFund) and Buddhist Tzuchi Foundation (covering all the expenses in Buddhist Tzuchi Hospital)

The study shows: "The lithium treatment did not change the neurological outcomes of patients with chronic spinal cord injury. It is worth to investigate whether lithium is effective in the treatment of neuropathic pain in chronic spinal cord injury (quoted form the Publication)".

For more information, please refer to:

1. Clinical trial registration: NCT00750061

2. Publication: Efficacy and safety of lithium carbonate treatment of chronic spinal cord injuries: a double-blind, randomized, placebo-controlled clinical trial Spinal Cord 50, 141-146 (February 2012) | doi:10.1038/sc.2011.126

To read more:

About Clinical Research

About Lithium and Cord Blood Cells

Registry for Trial Participation
Copyright © 2020. CHINASCINET
About Us | SCI Info | Studies | Events | ISCITT | Contact